Bioinformatics software provider InforMax of Rockville, Md., has released GenoMax 3.0, the next generation of the company’s enterprise bioinformatics system, including modules for sequence analysis, gene expression analysis, and three-dimensional protein structure. The company is developing new modules for genomic viewing, protein-protein interaction and single-nucleotide-polymorphism analysis that will be integrated with GenoMax. The product facilitates analysis of both public and proprietary genetic data sets within the security of the corporate firewall, said the company.
Compugen of Tel Aviv, Israel, has launched its first proteomics software product, called Z3 high-throughput 2D gel electrophoresis analysis system. According to Compugen, Z3 automates the 2D gel analysis process by using proprietary algorithms for gel comparisons and the computation of differential expression. The Z3 system is available for licensing and by a pay-per-gel subscription model. In addition, Compugen has been beta testing its Z3-based 2D gel image analysis service to be offered as part of LabOnWeb.com, the company’s life science research engine for genomic, proteomic, and transcriptomic analysis.
Rosetta Inpharmatics of Kirkland, Wash., has developed a new file format, called Gene Expression Markup Language, to facilitate the interchange of data from DNA chips and other gene expression technologies into a consistent format for more efficient and extensive data analysis. GEML may be helpful in reading molecular signatures of cancer and other diseases through various technology platforms, the company said.